These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2926577)

  • 21. Effects of clorazepate, diazepam, lorazepam, and placebo on human memory.
    Healey M; Pickens R; Meisch R; McKenna T
    J Clin Psychiatry; 1983 Dec; 44(12):436-9. PubMed ID: 6140261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relation between lorazepam-induced auditory amnesia and auditory evoked potentials.
    Samra SK; Bradshaw EG; Pandit SK; Papanicolaou AC; Moore BD
    Anesth Analg; 1988 Jun; 67(6):526-33. PubMed ID: 3377206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of sedative and amnestic doses of lorazepam in children.
    Henry DW; Burwinkle JW; Klutman NE
    Clin Pharm; 1991 Aug; 10(8):625-9. PubMed ID: 1934919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam.
    Brignell CM; Rosenthal J; Curran HV
    J Psychopharmacol; 2007 Sep; 21(7):673-83. PubMed ID: 17606475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive effects of beta-adrenergic antagonists after single doses: pharmacokinetics and pharmacodynamics of propranolol, atenolol, lorazepam, and placebo.
    Greenblatt DJ; Scavone JM; Harmatz JS; Engelhardt N; Shader RI
    Clin Pharmacol Ther; 1993 May; 53(5):577-84. PubMed ID: 8098277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
    Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of hydroxyzine on attention and memory in elderly subjects].
    De Brabander A; Deberdt W
    Acta Psychiatr Belg; 1992; 92(6):370-82. PubMed ID: 1345410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic drug clearance in children with leukemia: changes in clearance of model substrates during remission-induction therapy.
    Relling MV; Crom WR; Pieper JA; Cupit GC; Rivera GK; Evans WE
    Clin Pharmacol Ther; 1987 Jun; 41(6):651-60. PubMed ID: 3472701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sedation and memory: studies with a histamine H-1 receptor antagonist.
    Turner C; Handford AD; Nicholson AN
    J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of neurotrauma on hepatic drug clearance.
    Boucher BA; Kuhl DA; Fabian TC; Robertson JT
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):487-97. PubMed ID: 1934861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose oral lorazepam administration in Alzheimer subjects and age-matched controls.
    Sunderland T; Weingartner H; Cohen RM; Tariot PN; Newhouse PA; Thompson KE; Lawlor BA; Mueller EA
    Psychopharmacology (Berl); 1989; 99(1):129-33. PubMed ID: 2506598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lorazepam in children. A double-blind trial comparing lorazepam, diazepam, trimeprazine and placebo.
    Burtles R; Astley B
    Br J Anaesth; 1983 Apr; 55(4):275-9. PubMed ID: 6132612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.
    Friedman H; Redmond DE; Greenblatt DJ
    Psychopharmacology (Berl); 1991; 104(1):103-5. PubMed ID: 1881994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver volume as a determinant of drug clearance in children and adolescents.
    Murry DJ; Crom WR; Reddick WE; Bhargava R; Evans WE
    Drug Metab Dispos; 1995 Oct; 23(10):1110-6. PubMed ID: 8654200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of experimentally induced sleep disturbance on the pharmacokinetics of lorazepam in healthy volunteers.
    Kotegawa T; Tsutsumi K; Imai H; Ohashi K; Nakano S
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):519-24. PubMed ID: 24755136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects.
    Siepmann M; Heine B; Kluge A; Ziemssen T; Mück-Weymann M; Kirch W
    Clin Auton Res; 2007 Jun; 17(3):160-4. PubMed ID: 17390103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sedative effects and impaired learning and recall after single oral doses of lorazepam.
    Shader RI; Dreyfuss D; Gerrein JR; Harmatz JS; Allison SJ; Greenblatt DJ
    Clin Pharmacol Ther; 1986 May; 39(5):526-9. PubMed ID: 3698460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus.
    Chamberlain JM; Capparelli EV; Brown KM; Vance CW; Lillis K; Mahajan P; Lichenstein R; Stanley RM; Davis CO; Gordon S; Baren JM; van den Anker JN;
    J Pediatr; 2012 Apr; 160(4):667-672.e2. PubMed ID: 22050870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.